Histamine H3 receptor: a potential drug target for the treatment of central nervous system disorders
LF Alguacil, C Pérez-García - Current Drug Targets-CNS & …, 2003 - ingentaconnect.com
Histamine H3 receptors were first described in the eighties but finally cloned four years ago.
They are G-protein coupled, mostly presynaptic, and are involved in the control of the …
They are G-protein coupled, mostly presynaptic, and are involved in the control of the …
Histamine H3 and H4 receptors as novel drug targets
E Tiligada, E Zampeli, K Sander… - Expert opinion on …, 2009 - Taylor & Francis
The identification of histamine H3 (H3R) and H4 (H4R) receptors some years ago revived
interest in histamine research and exposed attractive perspectives for the potential …
interest in histamine research and exposed attractive perspectives for the potential …
The histamine H3 receptor: structure, pharmacology, and function
G Nieto-Alamilla, R Márquez-Gómez… - Molecular …, 2016 - ASPET
Among the four G protein–coupled receptors (H1–H4) identified as mediators of the biologic
effects of histamine, the H3 receptor (H3R) is distinguished for its almost exclusive …
effects of histamine, the H3 receptor (H3R) is distinguished for its almost exclusive …
Recent advances in histamine H3/H4 receptor ligands
H Stark - Expert Opinion on Therapeutic Patents, 2003 - Taylor & Francis
Advances in molecular biology have brought fresh impetus to the field of research into
histamine receptor ligands with the recent cloning of human histamine H3 and H4 receptors …
histamine receptor ligands with the recent cloning of human histamine H3 and H4 receptors …
Histamine H3 receptor function and ligands: recent developments
Histamine H3 receptors are found mostly in central nervous system involved in the
regulation of release of various neurotransmitters in brain. They have been implicated in …
regulation of release of various neurotransmitters in brain. They have been implicated in …
A third histamine receptor subtype: Characterisation, localisation and functions of the H3-receptor
JC Schwartz, JM Arrang, M Garbarg, H Pollard - Agents and Actions, 1990 - Springer
Conclusions The discovery of the third histamine receptor and the design of highly selective
and potent ligands have not only clarified some aspects of histaminergic neurotransmission …
and potent ligands have not only clarified some aspects of histaminergic neurotransmission …
The histamine H3 receptor as a therapeutic drug target for CNS disorders
MJ Gemkow, AJ Davenport, S Harich, BA Ellenbroek… - Drug discovery today, 2009 - Elsevier
The histamine H3 receptor plays a regulatory role in the pre-synaptic release of histamine
and other neurotransmitters, making it an attractive target for CNS indications including …
and other neurotransmitters, making it an attractive target for CNS indications including …
The histamine H3 receptor: from discovery to clinical trials with pitolisant
JC Schwartz - British journal of pharmacology, 2011 - Wiley Online Library
The third histamine receptor was discovered in 1983 by a traditional pharmacological
approach, consisting of assessing the inhibitory effect of histamine on its own release from …
approach, consisting of assessing the inhibitory effect of histamine on its own release from …
The histamine H3 receptor: an attractive target for the treatment of cognitive disorders
TA Esbenshade, KE Browman… - British journal of …, 2008 - Wiley Online Library
The histamine H3 receptor, first described in 1983 as a histamine autoreceptor and later
shown to also function as a heteroreceptor that regulates the release of other …
shown to also function as a heteroreceptor that regulates the release of other …
[HTML][HTML] The histamine H3 receptor: from gene cloning to H3 receptor drugs
R Leurs, RA Bakker, H Timmerman… - Nature reviews Drug …, 2005 - nature.com
Since the cloning of the histamine H3 receptor cDNA in 1999 by Lovenberg and co-workers,
this histamine receptor has gained the interest of many pharmaceutical companies as a …
this histamine receptor has gained the interest of many pharmaceutical companies as a …